Skip to main content
Global Edition
Thursday, March 28, 2024

Plasma from recovered patients may help treat COVID-19

Credit: Reuters - 3D Animations (Next Me
Duration: 00:58s 0 shares 1 views

Plasma from recovered patients may help treat COVID-19
Plasma from recovered patients may help treat COVID-19
Blood plasma from recovered patients may help treat other COVID-19 patients.

For story suggestions or custom animation requests, contact tips@nextanimation.com.tw.

Visit http://archive.nextanimationstudio.com to view News Direct's complete archive of 3D news animations.

RESTRICTIONS: Broadcast: NO USE JAPAN, NO USE TAIWAN Digital: NO USE JAPAN, NO USE TAIWAN Chinese researchers say blood plasma from recovered patients may help other COVID-19 patients to survive.

China National Biotec Group said it is taking plasma taken from recovered COVID-19 patients to treat those who are critically ill.

The state-owned pharmaceutical made those remarks in a news release dated Feb.

13.

The group claims a round of the treatment improved the patient's condition significantly after 12 to 24 hours, including reduced inflammation and improved blood oxygen levels, lymphocyte counts, and reduced viral load.

Citing an unnamed expert, the group states that this plasma contains special antibodies which were used to treat COVID-19 in the critically ill.

The group says the procedure was tested successfully in over 10 patients and asserts that it is the best available option for reducing mortality rates.

China Daily reports the president of Wuhan's Jinyintan Hospital called for plasma donations on Feb.

13.

RUNDOWN SHOWS: 1.

Blood plasma from recovered patients might be a treatment for COVID-19 2.

Plasma treatment significantly improved conditions for the critically ill 3.

Special antibodies from the plasma have been clinically utilized 4.

Clinical trial showed success for 10 patients VOICEOVER (in English): "China National Biotec Group said it is taking plasma taken from recovered COVID-19 patients to treat those who are critically ill.

The state-owned pharmaceutical made those remarks in a news release dated Feb.

13." "The group claims a round of the treatment improved the patient's condition significantly after 12 to 24 hours, including reduced inflammation and improved blood oxygen levels, lymphocyte counts, and reduced viral load." "Citing an unnamed expert, the group states that this plasma contains special antibodies which were used to treat COVID-19 in the critically ill." "The group says the procedure was tested successfully in over 10 patients and asserts that it is the best available option for reducing mortality rates.

China Daily reports the president of Wuhan's Jinyintan Hospital called for plasma donations on Feb.

13." SOURCES: China National Biotech Group (WeChat), Bloomberg, China Daily https://mp.weixin.qq.com/s?__biz=MzA5MzYyMjg3Nw==&mid=2650277425&idx=1&sn=ac0d81c6e70fd375e60ca22d7d24fa95&chksm=8857a103bf2028157e09556def05f0218c5471c1d971d344e470ea0f15e94dec50d109124aca&mpshare=1&scene=1&srcid=0214Gl4uglGbR818tq2NtkW1&sharer_sharetime=1581645361400&sharer_shareid=43bf103a1eed26107a95ebb1c7d24e37&exportkey=Aas2m1%2BUdUWarZ%2BD5Hy%2B3b4%3D&pass_ticket=D2NTBG8gJo6znvmq9j1%2BLWVAI2454ghMXv%2F6sgerpqwBc1gr3SLvRggxUoGks3YL#rd https://www.bloomberg.com/news/articles/2020-02-14/china-seeks-plasma-from-recovered-patients-for-coronavirus-cure?sref=hBxgxhfN https://www.chinadaily.com.cn/a/202002/14/WS5e45f72aa3101282172777cb.html *** For story suggestions please contact tips@nextanimation.com.tw For technical and editorial support, please contact: Asia: +61 2 93 73 1841 Europe: +44 20 7542 7599 Americas and Latam: +1 800 738 8377

You might like

Related news coverage

Advertisement